Target intelligence / Profile preview

Hepatitis B virus-infected hepatocyte

Molecular classification
Other
01

Overview

A "Hepatitis B virus-infected hepatocyte" is a liver epithelial cell (hepatocyte) that has been infected by the Hepatitis B virus (HBV), a DNA virus from the hepadnaviridae family[1][2][4][5]. After entry, HBV delivers its DNA genome into the host cell nucleus, where it forms a persistent covalently closed circular DNA (cccDNA) minichromosome, serving as the template for all viral RNAs[4][2]. These infected hepatocytes produce and secrete viral proteins (HBsAg, HBcAg, HBeAg), infectious virions, and non-infectious subviral particles[1][2]. HBV-infected hepatocytes are the main source of circulating HBV antigens and critical mediators of immune responses, viral persistence, and disease pathogenesis. Chronic infection of these cells can lead to progressive liver inflammation, fibrosis, and ultimately hepatocellular carcinoma, reflecting their key roles in both infection and liver disease progression[4][6]. Although not a single molecular target, but rather a cellular compartment affected by HBV, "hepatitis B virus-infected hepatocyte" is a key concept in the study of HBV biology, antiviral drug development, and immunopathology.

Other names
HBV-infected hepatocyteHBV-infected liver cellhepatitis B-infected hepatocyteinfected hepatocyte (HBV)HBV-positive hepatocyte
02

Mechanism of action

Viral polymerase inhibition; Reverse transcriptase inhibition; Immune modulation (e.g., interferons)

03

Biological functions

InfectionHost cell for viral replicationImmune response modulationFibrogenesis (when infected with HBV, induces secretion of collagen VI)
04

Disease associations

InfectionCancer (hepatocellular carcinoma development via chronic HBV infection)InflammationLiver fibrosis and cirrhosis
05

Safety considerations

Drug-induced liver injuryViral resistanceImmune-mediated liver damage during therapyReactivation of HBV
06

Interacting drugs

Nucleos(t)ide analogues (e.g., entecavir, tenofovir)

4 more in the full profile.

07

Biomarkers

Hepatitis B surface antigen (HBsAg)Hepatitis B core antigen (HBcAg)Hepatitis B envelope antigen (HBeAg)HBV DNA (serum)Covalently closed circular DNA (cccDNA) in hepatocytes

Beyond the preview

Go deeper on Hepatitis B virus-infected hepatocyte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis B virus-infected hepatocyte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call